US20260109752A1: Extracellular Vesicle Platforms for Therapeutic Delivery
Summary
USPTO patent application US20260109752A1 covers platforms for generating extracellular vesicles, compositions of extracellular vesicles, and methods of using extracellular vesicles for therapeutics delivery. The application was filed on October 2, 2025 by inventors Milad Riazifar, Charles Cameron Taylor, and Todd Schurr (application No. 19348356). This is a publication of a patent application, not a granted patent.
About this source
GovPing monitors USPTO Patent Applications - Therapeutics (A61P) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 226 changes logged to date.
What changed
USPTO patent application US20260109752A1 discloses platforms for generating extracellular vesicles, compositions of extracellular vesicles, and methods for using extracellular vesicles in therapeutics delivery. The application lists CPC classifications including C07K 14/70521, A61K 9/5068, and A61P 29/00, indicating therapeutic applications. Inventors are Milad Riazifar, Charles Cameron Taylor, and Todd Schurr.
For pharmaceutical and biotechnology companies, this patent application represents potential prior art for freedom-to-operate analyses in the extracellular vesicle drug delivery space. Companies developing similar therapeutic delivery platforms should review the claims when the application proceeds to grant to assess potential infringement risks.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
PLATFORMS, COMPOSITIONS, AND METHODS FOR THERAPEUTIC DELIVERY
Application US20260109752A1 Kind: A1 Apr 23, 2026
Inventors
Milad RIAZIFAR, Charles Cameron TAYLOR, Todd SCHURR
Abstract
Descried herein are platforms for generating extracellular vesicles. Described herein are compositions of extracellular vesicles. Also described herein are methods of using the extracellular vesicles for therapeutics delivery.
CPC Classifications
C07K 14/70521 A61K 9/5068 A61K 47/42 A61P 29/00 C07K 14/70503 C07K 14/70532 C07K 14/70596 A61K 38/00 C07K 2319/03
Filing Date
2025-10-02
Application No.
19348356
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.